Taylor Cancer Research Center (site 204)

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma	Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Stomatognathic Diseases, Thoracic Neoplasms, adenocarcinoma, adenoid cystic carcinoma, adenoma, bronchial neoplasm, bronchogenic carcinoma, carcinoma, digestive system disorder, digestive system neoplasm, endocrine system disorder, epithelial neoplasm, esophageal cancer, esophageal disorder, head and neck carcinoma, head and neck squamous cell carcinoma, laryngeal disorder, lung cancer, lung disorder, lung neoplasm, malignant endocrine neoplasm, malignant pancreatic neoplasm, mesothelial neoplasm, mesothelioma, mouth disorder, neoplasm, non-small cell lung carcinoma, otorhinolaryngologic disease, pancreas disorder, pancreatic neoplasm, respiratory system disorder, respiratory tract neoplasm, salivary gland cancer, salivary gland disorder, small cell lung carcinoma, squamous cell carcinoma, tracheal disorder	Recruiting	Phase 1 / Phase 2	2025-12-11		NCT03556228

Clinical trials